
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
EVTG | Xetra | EUR | Delayed | |
EVTd | BATS Europe | EUR | Delayed | |
1EVT | Milan | EUR | Real-time | |
EVTG | Frankfurt | EUR | Delayed | |
EVTG | TradeGate | EUR | Delayed | |
EVTG | Vienna | EUR | Real-time |
Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic disease, and rare diseases; central nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. It has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. The company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
Name | Age | Since | Title |
---|---|---|---|
Iris Low-Friedrich | 62 | 2014 | Independent Chairperson of the Supervisory Board |
Roland Sackers | 56 | 2019 | Independent Vice Chairperson of the Supervisory Board |
Constanze Ulmer-Eilfort | 61 | 2021 | Independent Member of Supervisory Board |
Sujata M. Bhavnani | - | 2024 | Member of the Scientific Advisory Board |
Manu Shankar Hari | - | 2024 | Member of the Scientific Advisory Board |
T. Mark Miller | - | 2024 | Member of the Scientific Advisory Board |
Camilla Macapili Languille | 41 | 2022 | Member of the Supervisory Board |
Duncan McHale | 57 | 2024 | Member of the Supervisory Board |
Wesley Potter Wheeler | 68 | 2024 | Independent Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review